Mon, Jan
70 New Articles

Sayenko Kharenko Helps AbbVie Obtain Ukrainian Merger Clearance for Acquisition of Allergan

Sayenko Kharenko Helps AbbVie Obtain Ukrainian Merger Clearance for Acquisition of Allergan

  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Sayenko Kharenko has helped AbbVie Inc. obtain merger clearance from the Anti-Monopoly Committee of Ukraine for its global USD 63 billion acquisition of Allergan plc.

AbbVie is a research-based global biopharmaceutical company that is, Sayenkp Kharenko reports, "committed to developing innovative, advanced therapies for some of the world’s most complex and critical conditions.”

Allergan is a manufacturer of pharmaceuticals that operates in more than 100 countries.

Sayenko Kharenko’s team included Partner Valentyna Hvozd, Senior Associate Anastasia Bodnar, and Associate Snizhanna Savka.

Editor's note: After this article was published, Prica & Partners informed CEE Legal Matters that it had acted as Serbian advisor to AbbVie on the deal. The firm's team was led by Partner Tijana Lalic.

Ukraine Knowledge Partner

AVELLUM is a leading Ukrainian full service law firm with a key focus on Finance, Corporate, Dispute Resolution, Tax, and Antitrust.

Our aim is to be the firm of choice for large businesses and financial institutions in respect of their most important and challenging transactions.

We build lasting relationships with our clients and make them feel secure in new uncertain economic and legal realities.

We incorporate the most advanced Western legal techniques and practices into our work. By adding our first-hand knowledge, broad industry experience, and unparalleled level of service we deliver the best results to our clients in their business endeavours. Our partners are taking an active role in every transaction and ensure smooth teamwork.

AVELLUM is recognised as one of the leading law firms in Ukraine by various international and Ukrainian legal editions (Chambers, The Legal500, IFLR1000, The Ukrainian Law Firms, and others).

Firm's website: www.avellum.com


Our Latest Issue